» Articles » PMID: 17395738

Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation

Overview
Journal Diabetes
Specialty Endocrinology
Date 2007 Mar 31
PMID 17395738
Citations 531
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is linked to a variety of metabolic disorders, such as insulin resistance and atherosclerosis. Dysregulated production of fat-derived secretory factors, adipocytokines, is partly responsible for obesity-linked metabolic disorders. However, the mechanistic role of obesity per se to adipocytokine dysregulation has not been fully elucidated. Here, we show that adipose tissue of obese mice is hypoxic and that local adipose tissue hypoxia dysregulates the production of adipocytokines. Tissue hypoxia was confirmed by an exogenous marker, pimonidazole, and by an elevated concentration of lactate, an endogenous marker. Moreover, local tissue hypoperfusion (measured by colored microspheres) was confirmed in adipose tissue of obese mice. Adiponectin mRNA expression was decreased, and mRNA of C/EBP homologous protein (CHOP), an endoplasmic reticulum (ER) stress-mediated protein, was significantly increased in adipose tissue of obese mice. In 3T3-L1 adipocytes, hypoxia dysregulated the expression of adipocytokines, such as adiponectin and plasminogen activator inhibitor type-1, and increased the mRNAs of ER stress marker genes, CHOP and GRP78 (glucose-regulated protein, 78 kD). Expression of CHOP attenuated adiponectin promoter activity, and RNA interference of CHOP partly reversed hypoxia-induced suppression of adiponectin mRNA expression in adipocytes. Hypoxia also increased instability of adiponectin mRNA. Our results suggest that hypoperfusion and hypoxia in adipose tissues underlie the dysregulated production of adipocytokines and metabolic syndrome in obesity.

Citing Articles

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.


Do Lifestyle Interventions Mitigate the Oxidative Damage and Inflammation Induced by Obesity in the Testis?.

Moreira R, Oliveira P, Spadella M, Ferreira R, Alves M Antioxidants (Basel). 2025; 14(2).

PMID: 40002337 PMC: 11851673. DOI: 10.3390/antiox14020150.


Association Between TyG-BMI Index and Hyperuricemia in Adult Women.

Mutailipu K, Guo J, Yin J, Wang Y, Lu L, Jia X Endocrinol Diabetes Metab. 2025; 8(2):e70028.

PMID: 39901609 PMC: 11791015. DOI: 10.1002/edm2.70028.


Associations between systemic immune-inflammatory index and visceral adipose tissue area: results of a national survey.

Liao Y, Zhou K, Lin B, Deng S, Weng B, Pan L Front Nutr. 2025; 11:1517186.

PMID: 39885869 PMC: 11780491. DOI: 10.3389/fnut.2024.1517186.


GSK3β Deficiency Expands Obese Adipose Vasculature to Mitigate Metabolic Disorders.

Wang L, Li J, Tang P, Zhu D, Tai L, Wang Y Circ Res. 2024; 136(1):91-111.

PMID: 39629559 PMC: 11692787. DOI: 10.1161/CIRCRESAHA.124.325187.